Evidence map›Paper›PMID 39559659›Full record

ArticleCureus2024

The Clot Stops Here: Insights Into Venous Thromboembolism Prophylaxis Adherence From Two Cases.

Anthony T Nguyen, Alexandra M Glaeser

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anthony T NguyenInternal Medicine, University of California Los Angeles, Los Angeles, USA.
Alexandra M GlaeserInternal Medicine, University of California Los Angeles, Los Angeles, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmacologic venous thromboembolism (VTE) prophylaxis is effective and essential in the inpatient setting for medically ill patients to prevent deep venous thromboses (DVTs) and pulmonary embolisms (PEs), especially in high-risk patients such as those with limited mobility and underlying malignancy. It is less clear how the primary team, including the nurses and physicians, work together to ensure adherence to VTE prophylaxis during hospitalizations, especially amongst different institutions with varied practices. This case series describes two cases of healthcare-associated VTE after refusal of VTE prophylaxis for several days and the resulting complications, including morbidity and mortality. In light of these two cases and recognition that healthcare-associated VTE is a wider public health problem, we suggest a multi-disciplinary and standardized protocol for physicians to follow to ensure VTE prophylaxis adherence that takes into account a VTE risk assessment calculator such as the Padua or Caprini scores. Furthermore, physicians should acknowledge VTE prophylaxis refusal, counsel patients, and document their findings in high-risk patients on a daily basis. This would be a full-circle approach that encourages patient education about this commonplace yet critical practice and the potential consequences of non-adherence.

Indexed as

interdisciplinary health teampulmonary embolism (pe)quality improvement and patient safetyvenous thromboembolism (vte)vte prevention

Identifiers

PMID39559659
PMCPMC11572766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.